KATELYN MOCK: Open Payments
NPI 1316670284 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 31 payments from 13 companies in 2025. Trend: 2023 $124 · 2024 $122 · 2025 $817
Food & beverage: $717Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $201 |
| GENZYME CORPORATION | 6 | $156 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $56 |
| LEO Pharma Inc. | 2 | $52 |
| Organon LLC | 3 | $35 |
| PFIZER INC. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
Products named: DUPIXENT, SKYRIZI, Winlevi, RINVOQ, ANZUPGO, CIBINQO, Rhapsido, EBGLYSS.
Industry payments across UT — which companies pay providers there.
